跳至主要内容
临床试验/CTIS2022-502345-10-00
CTIS2022-502345-10-00招募中1 期

The effect of oral folinic acid rescue therapy on pemetrexed induced neutropenia and other toxicity: A randomized open-label trial.

Amphia Hospital0 个研究点目标入组 50 人开始时间: 2022年10月20日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • =18 years old, Eligible for treatment with pemetrexed-based chemotherapy based on indication., ECOG performance score of 0-2., Subject is able and willing to sign the Informed Consent Form.

排除标准

  • Contraindications for treatment with folinic acid in line with the SmPC. a. Hypersensitivity to the active substance or to any of the excipients. b. Anaemia caused by vitamin B12 deficiency., The presence of clinically relevant drug-drug interactions, according to the current SmPC of folinic acid.

研究者

发起方
Amphia Hospital

相似试验